RBR-7nzwkpg招募中未知
Effects of treatment with oral anticoagulant associated with antibiotic therapy on clinical, immunological parameters, hospitalization and mortality in patients with suspected Covid-19 infection and positive d-dimer: a randomized clinical trial
niversidade do Sul de Santa Catarina0 个研究点开始时间: 2021年1月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 100Y（—）
入选标准
- •Patients over 18 years of age; clinical suspicion of Covid-19; oxygen saturation between 93% and 97%; at least one more symptom according to the Ministry of Health criteria including tiredness or shortness of breath; fever and chills reported; cough and loss of smell or taste; positive result for the D-dimer test
排除标准
- •Patients with active infectious diseases; immunosuppressive diseases or active cancer; pregnant or lactating women; known renal failure; current use of anticoagulants; contraindication to the use of Edoxaban or Moxifloxacin
研究者
相似试验
进行中（未招募）
1 期
Effect of anticoagulation therapy on clinical outcomes in COVID-19 (COVID-PREVENT)EUCTR2020-002282-33-DECharité - Universitaetsmedizin Berlin400
招募中
2 期
Comparison of the effects of Rivaroxaban and Apixaban with Heparin and Enoxaparin in patients undergoing gynecological oncological surgery.IRCT20220211053991N1Iran University of Medical Sciences80
进行中（未招募）
1 期
Monitoring the effect of blood thinners during percutaneous coronary interventioAnticoagulation during percutaneous coronary interventionEUCTR2020-005298-29-NLSt. Antonius Hospital120
招募中
4 期
Monitoring the effect of oral anticoagulants during cardiac catheterisatiocoronary artery diseasepercutaneous coronary intervention10011082NL-OMON50931Sint Antonius Ziekenhuis120
尚未招募
不适用
The benefit of EXtending oral blood thinning(antiCOAgulant) treatment after acute blockage of cerebral veins(cerebral venous thrombosis-CVT) (EX-COA CVT)CTRI/2017/08/009564niversity of Lisbon